North America Eubiotics Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The North American eubiotics market encompasses a range of microbial and microbial-derived feed supplements designed to modulate the gut microbiome of production animals, including poultry, swine, ruminants, and aquaculture species. Valued at approximately $1.74 billion in 2024, the regional segment has been tracked alongside a global market valued between $6.3 billion and $8.7 billion in 2025, reflecting differing scope definitions across industry sources. North America represents one of the most developed and regulated eubiotics markets in the world, driven by the region's intensive commercial livestock systems and a mature regulatory framework that increasingly restricts sub-therapeutic antibiotic use in animal feed.

• •Market scope covers probiotics, prebiotics, synbiotics, enzymes, organic acids, and postbiotics used in animal nutrition
• •Regional market was approximately $1.74 billion in 2024; broader market valuations in source data range from $6.3B to $8.7B globally in 2025 depending on product scope
• •Linked to the larger North America probiotics market, which is projected to reach $21.92 billion by 2030 at 8.2% CAGR

The primary catalyst for market expansion is the global shift away from antibiotic growth promoters in animal agriculture, accelerated by regulatory bans and voluntary industry commitments in major markets. In North America, heightened consumer awareness around food safety, animal welfare, and antibiotic residue has driven livestock producers and integrators to adopt eubiotic alternatives. Additionally, the growing commercial animal production sector, particularly in poultry and swine, combined with rising global protein demand, is expanding the addressable market for functional feed ingredients.

• •Regulatory and consumer pressure to eliminate antibiotic growth promoters from animal feed remains the dominant growth driver
• •Postbiotics market in North America specifically projected to reach $1,448.8 million by 2036 at 7.7% CAGR, indicating strong momentum for newer eubiotic categories
• •Rising global demand for protein and increasing commercial livestock production scales are expanding feed additive budgets

The market is broadly segmented by product type, probiotics (lactic acid bacteria, bacillus strains, yeasts), prebiotics (oligosaccharides, inulin), enzymes, organic acids, and the emerging postbiotics category, and by livestock application, with poultry representing the largest end-use segment followed by swine and ruminants. Regionally within North America, the United States dominates due to its large-scale concentrated animal feeding operations (CAFOs) and well-established feed manufacturing infrastructure, while Canada shows strong growth in the poultry and dairy sectors. Mexico is emerging as a growth market driven by expanding commercial livestock production and growing awareness of feed quality standards.

• •Poultry represents the largest livestock segment, followed by swine and ruminants (dairy and beef cattle)
• •United States holds the dominant regional share supported by large-scale livestock operations and integrated feed supply chains
• •Canada and Mexico are secondary growth markets, with Canada's dairy and poultry sectors and Mexico's expanding commercial production base

Who are the notable companies in the industry?

The competitive structure of the North American eubiotics market is moderately consolidated, featuring a mix of large, vertically integrated animal nutrition companies with fermentation and microbial manufacturing capabilities alongside a growing cohort of specialty producers focused on niche strains and advanced delivery technologies. The supply chain involves upstream strain selection and culture media supply, midstream fermentation and formulation at industrial scale, and downstream distribution through integrated feed mills and premix manufacturers. North American capacity is concentrated in regions with established agricultural and biotechnology manufacturing infrastructure, particularly in the U.S. Midwest, with a notable presence of contract manufacturing and technology licensing arrangements.

• •Market structure blends large diversified animal nutrition firms with fermentation scale against focused specialty producers emphasizing strain innovation and targeted applications
• •Core production routes include submerged fermentation for bacterial strains, yeast propagation for yeast-based products, and chemical synthesis for prebiotic oligosaccharides
• •Manufacturing and formulation capacity is concentrated in regions with established agricultural commodity and biotechnology infrastructure, with the U.S. representing the primary production hub for the region

What are the recent trends and outlook?

Looking ahead, the market is expected to continue its 7.8% annual growth trajectory through the decade, supported by the maturation of postbiotic products, increasing use of precision fermentation and synthetic biology for novel strain development, and expanding regulatory acceptance of eubiotic health claims in animal nutrition. Sustainability pressures and demand for reduced environmental impact in livestock production are expected to further accelerate adoption, as eubiotics can improve feed conversion efficiency and reduce nitrogen and phosphorus excretion. Ongoing consolidation through mergers and acquisitions is likely as larger animal nutrition conglomerates seek to capture proprietary strain portfolios and formulation expertise.

• •Postbiotics are emerging as a key growth category, offering stability and ease of handling advantages over live probiotic strains
• •Advances in strain genomics and precision fermentation are expected to unlock more targeted and efficacious eubiotic products
• •Sustainability mandates and environmental regulations on livestock emissions are anticipated to create additional tailwinds for adoption